3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
3
CNS
3
Lymphoid
2
Head & Neck
2
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Carcinoma, Renal Cell
9
Prostatic Neoplasms
8
Urinary Bladder Neoplasms
7
Melanoma
7
Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Ovarian Neoplasms
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Carcinoma, Merkel Cell
3
Squamous Cell Carcinoma of Head and Neck
2
Kidney Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Uterine Neoplasms
1
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Penile Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma, Non-Hodgkin
1
Interventions
Peripheral Blood Stem Cell Transplantation
6
Cyclophosphamide
6
fludarabine phosphate
5
Nivolumab
5
Mycophenolic Acid
5
Carboplatin
5
Whole-Body Irradiation
4
Radiotherapy
4
Filgrastim
4
Cyclosporine
4
Gemcitabine
3
Cisplatin
3
Busulfan
3
Antilymphocyte Serum
3
cabozantinib
2
cabazitaxel
2
Voriconazole
2
Thiotepa
2
Therapeutics
2
Standard of Care
2
Sirolimus
2
Polymerase Chain Reaction
2
Mitomycin
2
Methylprednisolone
2
Methotrexate
2
Melphalan
2
Itraconazole
2
Immunoglobulin G
2
Goserelin
2
Flow Cytometry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
cemiplimab
×
Genitourinary
×
Clear all
NCT06022029
2025-12-24
ON-5001
OncoNano Medicine, Inc.
Phase 1
Recruiting
168 enrolled